Latest stories on PRME
Prime Medicine to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Prime Medicine to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Prime Medicine transferred with Buy rating at Chardan
The Fly61 · neutralanalyst
BMO initiates Prime Medicine stock with outperform rating
Investing.com Analyst Ratings61 · neutralanalyst
BMO starts Prime Medicine at Outperform into 2027 readouts
The Fly61 · neutralanalyst
Prime Medicine initiated with an Outperform at BMO Capital
The Fly61 · neutralanalyst
Prime Medicine: Soon In The Clinic
Seeking Alpha58 · neutralanalyst
Prime Medicine: An Initial Prognosis
Seeking Alpha42 · neutralgeneral
Prime Medicine Advances First-in-Human Prime Editing Trial in Wilson Disease
TipRanks67 · bullishproduct/pr
Prime Medicine reports Q4 EPS (24c), consensus (26c)
The Fly48 · neutralearnings
Prime Medicine GAAP EPS of -$0.24 beats by $0.02, revenue of $1.15M beats by $0.04M
Seeking Alpha56 · neutralearnings
Prime Medicine, Inc. (PRME) files 8-K
SEC 8-K50 · neutralgeneral
Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates
StockTitan56 · neutralearnings
Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
StockTitan63 · neutralproduct/pr
Prime Medicine (PRME) Reaches Positive Resolution to Arbitration with Beam Therapeutics
Yahoo Top67 · bullishgeneral
Prime Medicine Beats Beam Therapeutics In Patent Dispute - But Both Are Investable
Seeking Alpha58 · neutralgeneral
PRME Surges 15% After Winning Arbitration Against Beam — Clears Path To Human Trials For Its Gene-Editing Drug
Stocktwits News73 · bullishgeneral
Prime Medicine Secures Arbitration Win, Paving Way for PM647 Clinical Advances—Key Dates and Pipeline Focus Stand Out
July 8, 2026
MarketChameleon67 · bullishproduct/pr
Prime Medicine gains after winning arbitration with Beam Therapeutics
Seeking Alpha67 · bullishgeneral
Prime Medicine resolves arbitration, clarifying PM647 development rights
TipRanks56 · neutralgeneral
Prime Medicine, Inc. (PRME) files 8-K
SEC 8-K50 · neutralgeneral
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics | PRME Stock News
StockTitan67 · bullishgeneral
Here’s Why H.C. Wainwright Upgraded Prime Medicine (PRME) To “Buy”
Yahoo Top61 · neutralanalyst